Sell in May and Go Away—Starting With These 3 Stocks

General News

Summary

Marc Lichtenfeld argues for trimming positions in three stocks—DexCom, Colgate-Palmolive, and Oracle—citing seasonality and individual red flags rather than predicting a market crash. He points to historical S&P seasonality that favors November–April over May–October and uses that as a discipline to exit weak positions. DexCom faces overcrowded bullish sentiment, competitive share loss and regulatory scrutiny; Colgate shows flat performance, insider selling and limited catalysts; Oracle carries massive data-center/lease commitments tied to AI partnerships that could require significant future financing. He recommends reallocating capital to names with clearer cash-flow visibility and yield rather than holding stocks with stretched valuation or financing risk.

Classifications

industries
Engineering
applications
Data Management

AskAI Classifications

Labels
Healthcare Software Digital Health SaaS

Linked Companies

Dexcom, Inc.
$1M to $5M
STARLIMS
$25M to $50M